All chronic kidney disease articles
-
NewsFDA-approved dialysis drug may help fight against antimicrobial resistance
In account of the imminent threat of antimicrobial resistance (AMR), a study revealed that the FDA-approved sevelamer, which is used to treat chronic kidney disease undergoing dialysis, is successful in the removal of other off-target antibiotics (vancomycin and daptomycin) from the gut.
-
NewsResearch ties gut microbial TMAO pathway to chronic kidney disease
A large-scale joint study shows a striking link between high blood levels of TMAO (trimethylamine N-oxide) and chronic kidney disease risk over time.